Your browser doesn't support javascript.
loading
The Impact of Immunoglobulin G1 Fc Sialylation on Backbone Amide H/D Exchange.
Kuhne, Felix; Bonnington, Lea; Malik, Sebastian; Thomann, Marco; Avenal, Cecile; Cymer, Florian; Wegele, Harald; Reusch, Dietmar; Mormann, Michael; Bulau, Patrick.
Afiliação
  • Kuhne F; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. felix.kuhne@roche.com.
  • Bonnington L; Institute of Hygiene, University of Muenster, Robert-Koch-Strasse 41, 48149 Muenster, Germany. felix.kuhne@roche.com.
  • Malik S; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. lea.bonnington@roche.com.
  • Thomann M; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. sebastian.malik@roche.com.
  • Avenal C; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. marco.thomann@roche.com.
  • Cymer F; Pharma Technical Development Analytics Biologics, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. cecile.avenal@roche.com.
  • Wegele H; Pharma Technical Development Analytics Biologics, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. florian.cymer@roche.com.
  • Reusch D; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. harald.wegele@roche.com.
  • Mormann M; Pharma Technical Development Analytics Biologics, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. harald.wegele@roche.com.
  • Bulau P; Pharma Technical Development, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany. dietmar.reusch@roche.com.
Antibodies (Basel) ; 8(4)2019 10 01.
Article em En | MEDLINE | ID: mdl-31581521
ABSTRACT
The usefulness of higher-order structural information provided by hydrogen/deuterium exchange-mass spectrometry (H/DX-MS) for the structural impact analyses of chemical and post-translational antibody modifications has been demonstrated in various studies. However, the structure-function assessment for protein drugs in biopharmaceutical research and development is often impeded by the relatively low-abundance (below 5%) of critical quality attributes or by overlapping effects of modifications, such as glycosylation, with chemical amino acid modifications; e.g., oxidation or deamidation. We present results demonstrating the applicability of the H/DX-MS technique to monitor conformational changes of specific Fc glycosylation variants produced by in vitro glyco-engineering technology. A trend towards less H/DX in Fc Cγ2 domain segments correlating with larger glycan structures could be confirmed. Furthermore, significant deuterium uptake differences and corresponding binding properties to Fc receptors (as monitored by SPR) between α-2,3- and α-2,6-sialylated Fc glycosylation variants were verified at sensitive levels.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article